Table 4.
Characteristics of those completing variceal obliteration and surveillance at 1-yr intervals n (%)
| Measures | 1-yr surveillance (n = 12) | Incomplete adherence (n = 87) | P value |
| Male | 7 (58) | 52 (60) | 1.0000 |
| Age, median (range), yr | 55 (45-78) | 54 (31-82) | 0.1936 |
| Etiology of cirrhosis | |||
| Alcohol | 6 (50) | 56 (64) | 0.3560 |
| Hepatitis C | 2 (17) | 10 (12) | 0.6364 |
| Other | 4 (33) | 21 (24) | 0.4918 |
| Recent alcohol use | 15 (45) | 42 (48) | 0.3726 |
| Distance from hospital, median (range), kilometers | 30.4 (3.7-80.3) | 13.7 (0.8-95.1) | 0.3898 |
| MELD score, median (range) | 11.5 (6-17) | 13 (7-27) | 0.2543 |
| Child-turcotte-pugh classification | |||
| A | 3 (25) | 21 (24) | 1.0000 |
| B | 6 (50) | 47 (54) | 1.0000 |
| C | 3 (25) | 19 (22) | 0.7259 |
| Index bleed in 2007 or earlier | 2 (17) | 42 (48) | 0.0607 |
| Medicaid1 or uninsured | 0 (0) | 31 (36) | 0.0160 |
| Comorbid psychiatric disorder | 5 (42) | 34 (39) | 1.0000 |
| Length of stay, median (range), d | 6 (3-7) | 5 (2-75) | 0.8808 |
| Beta-blocker at discharge | 12 (100) | 74 (85) | 0.3572 |
1
Government-sponsored health plan that assists with medical costs in selected low income individuals. MELD: Model for end-stage liver disease.